Literature DB >> 3898072

Heparin-treated, v-myc-transformed chicken heart mesenchymal cells assume a normal morphology but are hypersensitive to epidermal growth factor (EGF) and brain fibroblast growth factor (bFGF); cells transformed by the v-Ha-ras oncogene are refractory to EGF and bFGF but are hypersensitive to insulin-like growth factors.

S D Balk, T M Riley, H S Gunther, A Morisi.   

Abstract

Chicken heart mesenchymal cells do not proliferate in culture medium containing heat-defibrinogenated plasma but proliferate briskly when incubated with epidermal growth factor (EGF) or brain fibroblast growth factor (bFGF) plus insulin-like growth factors (IGFs) or when infected with sarcoma or erythroblastosis viruses. When infected with the retrovirus MC29, which bears a v-myc oncogene, chicken heart mesenchymal cells proliferate at a more modest rate and become morphologically transformed. Heparin at 25 microgram/ml causes these MC29-transformed cells to become proliferatively quiescent and to assume a normal morphology. Heparin-treated MC29-infected cells are, however, 100 times more sensitive to EGF than are their normal, uninfected counterparts. MC29-infected cells appear, likewise, to be hypersensitive to bFGF and to PDGF preparations but not to insulin. We hypothesize, therefore, (i) that heparin prevents the generation by cells of a mitogen from plasma protein precursors in the culture medium; (ii) that the v-myc oncogene renders cells hypersensitive to EGF, bFGF, PDGF, and the putative plasma-protein-derived mitogen; and (iii) that MC29-infected cells must proliferate in order to manifest the transformed morphology. Chicken heart mesenchymal cells infected with a recombinant spleen necrosis virus containing a v-ras oncogene are morphologically transformed but proliferate only sluggishly in plasma-containing medium without added mitogenic hormones. Heparin does not significantly affect their behavior. They are refractory to mitogenic stimulation by EGF or bFGF suggesting that ras proteins mediate the effects of receptors for these hormones. The SNV/v-ras-infected cells proliferate briskly, however, in response to hyperphysiological concentrations of insulin, an IGF surrogate, and are considerably more sensitive to this IGF mitogenicity than are their normal, uninfected counterparts.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3898072      PMCID: PMC390636          DOI: 10.1073/pnas.82.17.5781

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  Functional role for c-myc in mitogenic response to platelet-derived growth factor.

Authors:  H A Armelin; M C Armelin; K Kelly; T Stewart; P Leder; B H Cochran; C D Stiles
Journal:  Nature       Date:  1984 Aug 23-29       Impact factor: 49.962

2.  Suppression by heparin of smooth muscle cell proliferation in injured arteries.

Authors:  A W Clowes; M J Karnowsky
Journal:  Nature       Date:  1977-02-17       Impact factor: 49.962

3.  Active proliferation of Rous sarcoma virus-infected, but not normal, chicken heart mesenchymal cells in culture medium of physiological composition.

Authors:  S D Balk
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

4.  Mitogenic factors present in serum but not in plasma.

Authors:  S D Balk; S P Levine; L L Young; M M LaFleur; N M Raymond
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

5.  Morphological transformation, autonomous proliferation and colony formation by chicken heart mesenchymal cells infected with avian sarcoma, erythroblastosis and myelocytomatosis viruses.

Authors:  S D Balk; H S Gunther; A Morisi
Journal:  Life Sci       Date:  1984-09-10       Impact factor: 5.037

6.  Epidermal growth factor and insulin cause normal chicken heart mesenchymal cells to proliferate like their Rous sarcoma virus-infected counterparts.

Authors:  S D Balk; R P Shiu; M M LaFleur; L L Young
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

7.  Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells.

Authors:  J J Castellot; D L Beeler; R D Rosenberg; M J Karnovsky
Journal:  J Cell Physiol       Date:  1984-09       Impact factor: 6.384

8.  Phorbol 12-myristate 13-acetate, ionomycin or ouabain, and raised extracellular magnesium induce proliferation of chicken heart mesenchymal cells.

Authors:  S D Balk; A Morisi; H S Gunther
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

9.  Hormonal control of immunoreactive somatomedin production by cultured human fibroblasts.

Authors:  D R Clemmons; L E Underwood; J J Van Wyk
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

10.  An antiproliferative heparan sulfate species produced by postconfluent smooth muscle cells.

Authors:  L M Fritze; C F Reilly; R D Rosenberg
Journal:  J Cell Biol       Date:  1985-04       Impact factor: 10.539

View more
  8 in total

Review 1.  Calcium, cyclic AMP and protein kinase C--partners in mitogenesis.

Authors:  J F Whitfield; J P Durkin; D J Franks; L P Kleine; L Raptis; R H Rixon; M Sikorska; P R Walker
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 2.  Regulation of c-myc and c-fos proto-oncogene expression by animal cell growth factors.

Authors:  B J Rollins; C D Stiles
Journal:  In Vitro Cell Dev Biol       Date:  1988-02

3.  Expression of c-myc and bcl-2 oncogene products in Reed-Sternberg cells independent of presence of Epstein-Barr virus.

Authors:  N M Jiwa; P Kanavaros; P van der Valk; J M Walboomers; A Horstman; W Vos; H Mullink; C J Meijer
Journal:  J Clin Pathol       Date:  1993-03       Impact factor: 3.411

4.  Differential responsiveness of myc- and ras-transfected cells to growth factors: selective stimulation of myc-transfected cells by epidermal growth factor.

Authors:  D F Stern; A B Roberts; N S Roche; M B Sporn; R A Weinberg
Journal:  Mol Cell Biol       Date:  1986-03       Impact factor: 4.272

5.  Characterization of Apoptosis Signaling Cascades During the Differentiation Process of Human Neural ReNcell VM Progenitor Cells In Vitro.

Authors:  Alexandra Jaeger; Michael Fröhlich; Susanne Klum; Margareta Lantow; Torsten Viergutz; Dieter G Weiss; Ralf Kriehuber
Journal:  Cell Mol Neurobiol       Date:  2015-05-29       Impact factor: 5.046

6.  Epidermal growth factor stimulates rat cardiac adenylate cyclase through a GTP-binding regulatory protein.

Authors:  B G Nair; H M Rashed; T B Patel
Journal:  Biochem J       Date:  1989-12-01       Impact factor: 3.857

7.  Three cell lines showing androgen-dependent, -independent, and -suppressed phenotypes, established from a single tumor of androgen-dependent Shionogi carcinoma 115.

Authors:  T Yamaguchi; K Kawamoto; N Uchida; K Uchida; S Watanabe
Journal:  In Vitro Cell Dev Biol       Date:  1992-04

8.  An epigenetic predictor of death captures multi-modal measures of brain health.

Authors:  Robert F Hillary; Anna J Stevenson; Simon R Cox; Daniel L McCartney; Sarah E Harris; Anne Seeboth; Jon Higham; Duncan Sproul; Adele M Taylor; Paul Redmond; Janie Corley; Alison Pattie; Maria Del C Valdés Hernández; Susana Muñoz-Maniega; Mark E Bastin; Joanna M Wardlaw; Steve Horvath; Craig W Ritchie; Tara L Spires-Jones; Andrew M McIntosh; Kathryn L Evans; Ian J Deary; Riccardo E Marioni
Journal:  Mol Psychiatry       Date:  2019-12-03       Impact factor: 15.992

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.